355 related articles for article (PubMed ID: 35327655)
1. Is Autophagy Always a Barrier to Cisplatin Therapy?
Xu J; Gewirtz DA
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327655
[TBL] [Abstract][Full Text] [Related]
2. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
3. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species.
Magnano S; Hannon Barroeta P; Duffy R; O'Sullivan J; Zisterer DM
Toxicol Appl Pharmacol; 2021 Sep; 427():115646. PubMed ID: 34274415
[TBL] [Abstract][Full Text] [Related]
5. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.
Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA
Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell.
Choi BY; Joo JC; Lee YK; Jang IS; Park SJ; Park YJ
BMC Complement Altern Med; 2017 May; 17(1):277. PubMed ID: 28545442
[TBL] [Abstract][Full Text] [Related]
7. Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo.
Qu YQ; Song LL; Xu SW; Yu MSY; Kadioglu O; Michelangeli F; Law BYK; Efferth T; Lam CW; Wong VKW
Pharmacol Res; 2023 May; 191():106769. PubMed ID: 37061145
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient.
Aga T; Endo K; Tsuji A; Aga M; Moriyama-Kita M; Ueno T; Nakanishi Y; Hatano M; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2019 Jun; 46(3):443-450. PubMed ID: 30514592
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy.
Liu X; Sun K; Wang H; Dai Y
Neurosci Lett; 2016 May; 620():137-42. PubMed ID: 27048711
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics.
Yang Y; Liu L; Tian Y; Gu M; Wang Y; Ashrafizadeh M; Reza Aref A; Cañadas I; Klionsky DJ; Goel A; Reiter RJ; Wang Y; Tambuwala M; Zou J
Cancer Lett; 2024 Apr; 587():216659. PubMed ID: 38367897
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
[TBL] [Abstract][Full Text] [Related]
12. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
[TBL] [Abstract][Full Text] [Related]
13. Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment.
Berning L; Schlütermann D; Friedrich A; Berleth N; Sun Y; Wu W; Mendiburo MJ; Deitersen J; Brass HUC; Skowron MA; Hoffmann MJ; Niegisch G; Pietruszka J; Stork B
Molecules; 2021 Feb; 26(5):. PubMed ID: 33673611
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
[TBL] [Abstract][Full Text] [Related]
16. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.
Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B
Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062
[TBL] [Abstract][Full Text] [Related]
17. Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
Yin X; Zhang N; Di W
Int J Gynecol Cancer; 2013 May; 23(4):630-41. PubMed ID: 23518861
[TBL] [Abstract][Full Text] [Related]
18. Role of autophagy in cisplatin resistance in ovarian cancer cells.
Wang J; Wu GS
J Biol Chem; 2014 Jun; 289(24):17163-73. PubMed ID: 24794870
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI
Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
Bao LJ; Jaramillo MC; Zhang ZB; Zheng YX; Yao M; Zhang DD; Yi XF
Int J Clin Exp Pathol; 2014; 7(4):1502-13. PubMed ID: 24817946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
